default author photo

Francois Ghiringhelli

Centre Georges-François Leclerc - Department of Medical Oncology

Professor

1 rue Professeur Marion

Dijon

21000

France

  • Centre Georges-François Leclerc - Department of Medical Oncology

SCHOLARLY PAPERS

3

DOWNLOADS

187

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Hpv Circulating Tumor DNA to Monitor Response to Pembrolizumab and Vorinostat Combination in Patients with Advanced Hpv-Related Squamous Cell Carcinomas

Number of pages: 28 Posted: 21 Mar 2025
Daria Filippini, Bastien Cabarrou, Celia Dupain, Maral Halladjian, Elodie Coquan, Marie-Paule Sablin, Luca Mazzarella, Miguel Francisco, Nicolas Servant, Maria Manuela Tonini, Zahra Castel-Ajgal, Benoit You, Frédéric Bigot, Francois Ghiringhelli, Damien Vansteene, Carlos Gomez-Roca, Sophie Cousin, Aurélien Lambert, Esma Saada-Bouzid, Xavier Durando, Cyril Abdeddaim, Christian Borel, Raphaël Chaltiel, Edith Borcoman, François Legrand, Stephan Bernhart, Marta Jimenez, Ivan Bieche, Thomas Filleron, Christophe Le Tourneau, Maud Kamal and Emmanuelle Jeannot
Fondazione IRCCS Istituto Nazionale dei Tumori, affiliation not provided to SSRN, PSL Research University - Institut Curie, PSL Research University - Institut Curie, Centre François Baclesse - Department of Medical Oncology, PSL Research University - Institut Curie, European Institute of Oncology (IEO) IRCCS - Department of Experimental Oncology, PSL Research University - Institut Curie, PSL Research University - Institut Curie, affiliation not provided to SSRN, PSL Research University - Institut Curie, - Faculty of Medicine Lyon-Sud, affiliation not provided to SSRN, Centre Georges-François Leclerc - Department of Medical Oncology, Institut de Cancérologie de l’Ouest René Gauducheau - Department of Medical Oncology, affiliation not provided to SSRN, University of Bordeaux - Institut Bergonié, CHU Nancy, Centre Antoine Lacassagne, Centre Jean Perrin, University of Lille II - Centre Oscar Lambret, Institut de cancérologie Strasbourg Europe (ICANS), affiliation not provided to SSRN, PSL Research University - Institut Curie, UNICANCER, Leipzig University, UNICANCER, PSL Research University - Institut Curie, Institut Claudius Regaud, Institut Curie, PSL Research University - Institut Curie and PSL Research University - Institut Curie
Downloads 74

Abstract:

Loading...

circulating tumor DNA, HPV, squamous cell carcinoma, biomarker, pharmacodynamic, immunotherapy

2.

Twice-Iri: A Randomized Phase Iii Study Comparing Modified Folfiri3-Aflibercept to Folfiri-Aflibercept as Second-Line Therapy in Patients with Metastatic Colorectal Cancer

Downloads 66

Twice-Iri: A Randomized Phase Iii Study Comparing Modified Folfiri3-Aflibercept to Folfiri-Aflibercept as Second-Line Therapy in Patients with Metastatic Colorectal Cancer

Number of pages: 24 Posted: 17 Dec 2024
Benoist Chibaudel, Olivier Dubreuil, Julien Taieb, Christophe Borg, Francois Ghiringhelli, Romain Cohen, Jean Baptiste Bachet, May Mabro, M Jary, Elisabeth Carola, Marie Dior, Candice Carola, Nathalie Perez-Staub, Hélène Marijon, Nora Zeghib, Hubert Richa, Stefano Kim, Morteza Raeisi, Thierry André and Aimery de Gramont
Hôpital Franco-Britannique, Groupe Hospitalier Diaconesses-Croix St-Simon, Université Paris Cité, University of Besançon - University Hospital Besançon, Centre Georges-François Leclerc - Department of Medical Oncology, affiliation not provided to SSRN, Sorbonne University - Hôpital Pitié-Salpêtrière, Department of Gastroenterology, Sainte Catherine Institute, Université Clermont Auvergne - CHU Clermont-Ferrand, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Hôpital Franco-Britannique, Hôpital Franco-Britannique, Hôpital Franco-Britannique, Hôpital Franco-Britannique, affiliation not provided to SSRN, Fondation ARCAD, Sorbonne University and Hôpital Franco-Britannique
Downloads 39

Abstract:

Loading...

colorectal cancer, second-line, FOLFIRI, FOLFIRI3, aflibercept, antiangiogenic

TWICE-IRI: A Randomized Phase III Study Comparing Modified FOLFIRI3-Aflibercept to FOLFIRI-Aflibercept as Second-Line Therapy in Patients with Metastatic Colorectal Cancer

Number of pages: 24 Posted: 14 Mar 2025
Benoist Chibaudel, Olivier Dubreuil, Julien Taieb, Christophe Borg, Francois Ghiringhelli, Romain Cohen, Jean Baptiste Bachet, May Mabro, M Jary, Elisabeth Carola, Marie Dior, Candice Carola, Nathalie Perez-Staub, Hélène Marijon, Nora Zeghib, Hubert Richa, Stefano Kim, Morteza Raeisi, Thierry André and Aimery de Gramont
Hôpital Franco-Britannique, Groupe Hospitalier Diaconesses-Croix St-Simon, Université Paris Cité, University of Besançon - University Hospital Besançon, Centre Georges-François Leclerc - Department of Medical Oncology, affiliation not provided to SSRN, Sorbonne University - Hôpital Pitié-Salpêtrière, Department of Gastroenterology, Sainte Catherine Institute, Université Clermont Auvergne - CHU Clermont-Ferrand, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Hôpital Franco-Britannique, Hôpital Franco-Britannique, Hôpital Franco-Britannique, Hôpital Franco-Britannique, affiliation not provided to SSRN, Fondation ARCAD, Sorbonne University and Hôpital Franco-Britannique
Downloads 27

Abstract:

Loading...

colorectal cancer, Second-line, FOLFIRI, FOLFIRI3, aflibercept, antiangiogenic, chemotherapy

3.

Biliary Tract Cancers Have Distinct Epidemiological and Clinical Characteristics According to Tumour Site

Number of pages: 23 Posted: 18 Nov 2022
Francois Ghiringhelli, Valérie Jooste, Sylvain Manfredi, Audrey Hennequin, Come Lepage and Anne-Marie Bouvier
Centre Georges-François Leclerc - Department of Medical Oncology, INSERM UMR 1231 CADIR, INSERM UMR 1231 CADIR, Centre Georges-François Leclerc - Department of Medical Oncology, INSERM UMR 1231 CADIR and Centre Georges-François Leclerc - Department of Medical Oncology
Downloads 47

Abstract:

Loading...

Biliary tract cancer, Primary care, Real-life, Net survival, Epidemiology, Cancer registries